4//SEC Filing
ESBER HENRY JEMIL 4
Accession 0001437749-18-017792
CIK 0001411879other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:56 PM ET
Size
5.6 KB
Accession
0001437749-18-017792
Insider Transaction Report
Form 4
ESBER HENRY JEMIL
Director
Transactions
- Award
Restricted Stock Units
2018-10-01$0.12/sh+50,000$6,000→ 2,752,835 totalFrom: 2018-10-01Exp: 2028-10-01→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock.
- [F2]The Reporting Person was granted a Restricted Stock Unit on October 1, 2018 of 50,000 shares, which were fully vested on the date of the grant. The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the third quarter of 2018 and was valued on September 30, 2018 in accordance with the approved compensation plan for the non-employee members of the Board of Directors.
- [F3]These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan.
Documents
Issuer
INNOVUS PHARMACEUTICALS, INC.
CIK 0001411879
Entity typeother
Related Parties
1- filerCIK 0001391501
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 4:56 PM ET
- Size
- 5.6 KB